Azathioprine - BlackBoxRX.com

Azathioprine

Perform complete blood counts (including platelet counts) weekly during the first month, twice monthly for the second and third months, then monthly. Perform more frequently if dosage alterations or other therapy changes are necessary.
Monitor for infection. Infections may be fatal and should be treated aggressively.
Chronic immunosuppression with this agent may increase risk of neoplasia
Experienced Physician should be very familiar with mutagenic potential to both men and women and with possible hematologic toxicities.

Patient Counseling Information

Package Inserts

Updated June 2009

Disclaimer: This information presents a SUMMARY of Black Box data from product information labeling and does not address additional warnings, precautions, or other important safety data in the product insert. Patient care decisions SHOULD NOT be made without reviewing the most recent product information insert, which may be obtained from the manufacturer. This table may not be complete as it was prepared using product information from package inserts. It is periodically updated with supplemental information from FDA safety alerts, the FDA labeling announcements, and new drug approvals.

Formweb is a product of Formulary Productions, LLC. Visit our website at www.formweb.com for more information on online formularies featuring Black Box Warnings.
901-767-3000